Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nistala Kiran Insider Profile
4 Followers
Nistala Kiran, Chief Medical Officer and Head of Development at Zura Bio, holds 3.19K shares in Zura Bio (Ticker: ZURA). Most recently, Nistala Kiran Bought $3,195 shares of Zura Bio on Apr 24, 2024 for an estimated value of 10.00K.
Nistala Kiran has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief Medical Officer and Head of Development
Roles that Nistala Kiran holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Nistala Kiran
Nistala Kiran's Trading History
List of latest transactions for each holding click on a transaction to see Nistala Kiran's performance on stock
You May Also Like
Nistala Kiran insider profile FAQ
What is the percentage of profitable transactions made by Nistala Kiran?
The percentage of profitable transactions made by Nistala Kiran is ―.
What is the average return per transaction made by Nistala Kiran?
The average return per transaction made by Nistala Kiran is ―.
What stocks does Nistala Kiran hold?
Nistala Kiran holds: ZURA stocks.
What was Nistala Kiran’s latest transaction?
Nistala Kiran latest transaction was an Informative Buy of $10.00K.
What was Nistala Kiran's most profitable transaction?
Nistala Kiran’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Nistala Kiran's role in Zura Bio?
Nistala Kiran's role in Zura Bio is Chief Medical Officer and Head of Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.